CClinicalTrials.gg
CompletedNCT02265822Updated Oct 16, 2014

Melatonin Premedication in Children Undergoing Surgery

A Phase 4 interventional study of melatonin in children premedication and midazolam in children premedication in Premedication and Anaesthesia, sponsored by Azienda Ospedaliera Universitaria Policlinico "G. Martino". Completed. Open to participants aged 5 Years to 14 Years. Per ClinicalTrials.gov, last updated 2014-10-16.

Sponsored by Azienda Ospedaliera Universitaria Policlinico "G. Martino" · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
5 Years to 14 Years
Sex
All
01

Study summary

Melatonin has been proposed as alternative to midazolam as a premedication in procedures preceding anaesthesia induction. The objective of this prospective, randomized, double-blind study is to investigate the possible effect of melatonin premedication on the required infusion of propofol in comparison to midazolam, evaluating the efficacy of oral melatonin on sedation in children undergoing surgery.

Preoperative anxiety and postoperative analgesia are also assessed in both groups.

Read the detailed description

Children between the age of 5 and 14 years scheduled for elective surgery will be prospectively enrolled between September 2012 and October 2013. A physician will perform the clinical examination for each child, and anamnestic data will be collected in the medical records. Exclusion criteria will be: patients who had taken benzodiazepines, opioid drugs, or other sedative in the previous month; those who had sedation previously, or those with a temperament disorder, patients undergoing emergency surgery. Patients will be randomly assigned to 2 groups based on whether they will receive 0.2 mg/kg (max 5 mg) oral melatonin premedication (group A) or 0.5 mg/kg (max 20 mg) oral midazolam premedication (group B) before induction anaesthesia with propofol. For elective surgery, premedication will be performed between 07:30 and 09:30 h. Approximately 40 min before the induction of general anaesthesia, patients will be transported in a quiet room in the operating suite where they will receive orally melatonin or midazolam. The melatonin will be prepared by a dedicated resident in a fixed volume of 5 ml adding water in a syringe without needle. To simulate the sweet taste of the formulation of melatonin used, midazolam will be expanded to the fixed volume with 5% dextrose. The content of the syringe, in both cases marked with a coded label, will be blindly administrated to patients by the attendant nurse, not involved in the study. The child's level of sedation will be assessed and recorded by a resident before the premedication and 40 min after the administration of melatonin or midazolam, using the University of Michigan Sedation Scale (UMSS). In the operating room, an initial bolus dose of 1 mg/kg of intravenous propofol will be administered to both groups, followed by similar bolus doses of propofol until the patient will be anesthetized. Children will be considered anesthetized when asleep and not arousable. Anaesthesia will be maintained with inhalated sevoflurane. The total dose of propofol administrated will be recorded by the anaesthetist blinded to premedication group assignment. To provide objective information on the physical condition of patients after anaesthesia, Aldrete scale will be calculated after 10 min from conclusion of anaesthesia. Preoperative anxiety and postoperative analgesia will be also assessed in both groups.

02

Conditions studied

  • Premedication
  • Anaesthesia

Keywords

  • melatonin
  • midazolam
  • children
03

In context

Lead sponsor

Azienda Ospedaliera Universitaria Policlinico "G. Martino" is the lead sponsor of 16 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children between the age of 5 and 14 years scheduled for elective surgery

Exclusion criteria

Exclusion Criteria:

  • Patients who had taken benzodiazepines, opioid drugs, or other sedative in the previous month
  • Those who had sedation previously, or those with a temperament disorder, patients undergoing emergency surgery
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
92 participants (actual)

Study arms

  • Experimental
    melatonin

    0.5 mg/kg (max 20 mg) oral melatonin premedication will be administered approximately 40 min before the induction of general anaesthesia with propofol. The melatonin will be prepared in a fixed volume of 5 ml adding water in a syringe without needle.

    Drug: melatonin in children premedication

  • Active comparator
    midazolam

    0.5 mg/kg (max 20 mg) oral midazolam premedication will be administered approximately 40 min before the induction of general anaesthesia with propofol. The melatonin will be prepared in a fixed volume of 5 ml adding 5% dextrose in a syringe without needle.

    Drug: midazolam in children premedication

Interventions

  • Drugmelatonin in children premedication
  • Drugmidazolam in children premedication
06

What researchers measure

Primary outcomes

  1. efficacy of melatonin as premedicant in children undergoing elective surgery

    the required infusion of propofol required during induction of general anaesthesia in both groups will be evaluated

    Time frame: day 1: 40-45 min after melatonin or midazolam premedication

Secondary outcomes

  1. effect of melatonin premedication in postoperative analgesia in children undergoing elective surgery

    The child's level of sedation will be assessed and recorded using the University of Michigan Sedation Scale (UMSS).

    Time frame: day 1: 40 min after melatonin or midazolam premedication

  2. effect of melatonin premedication in postoperative analgesia in children undergoing elective surgery

    post procedural pain will be assessed and recorded in both groups

    Time frame: day 1: 3, 6, and 12 hours post surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Acil M, Basgul E, Celiker V, Karagoz AH, Demir B, Aypar U. Perioperative effects of melatonin and midazolam premedication on sedation, orientation, anxiety scores and psychomotor performance. Eur J Anaesthesiol. 2004 Jul;21(7):553-7. doi: 10.1017/s0265021504007094. PubMed 15318468 ↗
  • Naguib M, Gottumukkala V, Goldstein PA. Melatonin and anesthesia: a clinical perspective. J Pineal Res. 2007 Jan;42(1):12-21. doi: 10.1111/j.1600-079X.2006.00384.x. PubMed 17198534 ↗
  • Naguib M, Samarkandi AH, Moniem MA, Mansour Eel-D, Alshaer AA, Al-Ayyaf HA, Fadin A, Alharby SW. The effects of melatonin premedication on propofol and thiopental induction dose-response curves: a prospective, randomized, double-blind study. Anesth Analg. 2006 Dec;103(6):1448-52. doi: 10.1213/01.ane.0000244534.24216.3a. PubMed 17122221 ↗
  • Kurdi MS, Patel T. The role of melatonin in anaesthesia and critical care. Indian J Anaesth. 2013 Mar;57(2):137-44. doi: 10.4103/0019-5049.111837. PubMed 23825812 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02265822
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Collaborators
Eloisa Gitto, Lucia Marseglia, Gabriella D'Angelo, Sara Manti, Simona Montalto, Pietro Impellizzeri
Responsible party
Carmelo Romeo MD, MSc (Professor, Azienda Ospedaliera Universitaria Policlinico) — Principal investigator
First posted
Oct 16, 2014
Start date
Sep 2012
Primary completion
Oct 2013
Completion
Oct 2013
Last update
Oct 16, 2014

Study contacts

Carmelo Romeo, Prof
study chair · Azienda Ospedaliera Universitaria Policlinico "G. Martino"

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion